Predictive Models of Intensive Care Unit Mortality - Severity of Illness Scores or Artificial Intelligence instruments? - Literature Review and Metanalysis (Preprint)

2021 ◽  
Author(s):  
Cristina Barboi ◽  
Andreas Tzavelis ◽  
Lutfiyya NaQiyba Muhammad

BACKGROUND The Severity of Illness Scores (SIS)- Acute Physiology and Chronic Health Evaluation (APACHE), Simplified Acute Physiology Score (SAPS), and Sequential Organ Failure Assessment (SOFA) - are current risk stratification and mortality prediction tools used in Intensive Care Units (ICU) across the globe, and rely on scores that assess disease severity on admission. Developers of Artificial Intelligence (AI) or Machine Learning (ML) models predictive of ICU mortality use the SIS performance as a reference point when reporting the performance of these computational constructs. OBJECTIVE Using systematic review and meta-analysis, we evaluated studies that compare ML-based mortality prediction models to SIS-based models. The review should inform clinicians regarding the prognostic value of ML-based ICU mortality prediction models compared with SIS models and their validity in supporting clinical decision-making. METHODS We performed a systematic search using PubMed, Scopus, Embase, and IEEE databases. Studies that report the performance of newly developed ML models predictive of ICU mortality and compare it with the performance of SIS models on the same datasets were eligible for inclusion. ML and the SIS models with a reported Area Under the Receiver Operating Characteristic (AUROC) curve were included in the meta-analysis to identify the group with superior performance. Data were extracted with guidance from the CHARMS (Critical Appraisal and Data Extraction for Systematic Reviews of Prediction Modelling Studies) checklist[1] and was appraised for risk of bias and applicability using PROBAST (A Tool to Assess the Risk of Bias and Applicability of Prediction Model Studies ) [2]. RESULTS After screening the literature, we identified and included 20 papers containing 47 ML models based on seven types of algorithms that were compared with three types of SIS models. The AUROC for predicting ICU mortality ranged between 0.828-0.875 for ML-based models and between 0.707-0.760 for SI-based models. We noted substantial heterogeneity among the models reported, and considerable variation among the AUROC estimates for both ML and SIS model types. Due to the high degree of heterogeneity, we performed a limited random-effect meta-analysis of externally validated subgroups of ML models and the subgroups of SIS used for comparison. CONCLUSIONS ML-based models can accurately predict ICU mortality as an alternative to traditional scoring models. The high degree of heterogeneity observed within and between studies limit the assessment of pooled results. The differences in development strategies, validation, statistical, and computational methods that these models rely on impede a head-to-head comparison, and we cannot declare the superiority of one model over the other. Consequently, we make no recommendation regarding the ML-based ICU mortality prediction models’ performance in clinical practice. To bridge the knowledge gap from design to practice, ML model developers must provide explainer models and make those knowledge objects reproducible, interoperable, and transparent[3]. CLINICALTRIAL the review was registered and approved by the international prospective register of systematic reviews, PROSPERO (reference number CRD42021203871).

2021 ◽  
Vol 21 (1) ◽  
Author(s):  
Alcade Rudakemwa ◽  
Amyl Lucille Cassidy ◽  
Théogène Twagirumugabe

Abstract Background Reasons for admission to intensive care units (ICUs) for obstetric patients vary from one setting to another. Outcomes from ICU and prediction models are not well explored in Rwanda owing to lack of appropriate scores. This study aimed to assess reasons for admission and accuracy of prediction models for mortality of obstetric patients admitted to ICUs of two public tertiary hospitals in Rwanda. Methods We prospectively collected data from all obstetric patients admitted to the ICUs of the two public tertiary hospitals in Rwanda from March 2017 to February 2018 to identify reasons for admission, demographic and clinical characteristics, outcome including death and its predictability by both the Modified Early Obstetric Warning Score (MEOWS) and quick Sequential Organ Failure Assessment (qSOFA). We analysed the accuracy of mortality prediction models by MEOWS or qSOFA by using logistic regression adjusting for factors associated with mortality. Area under the Receiver Operating characteristic (AUROC) curves is used to show the predicting capacity for each individual tool. Results Obstetric patients (n = 94) represented 12.8 % of all 747 ICU admissions which is 1.8 % of all 4.999 admitted women for pregnancy or labor. Sepsis (n = 30; 31.9 %) and obstetric haemorrhage (n = 24; 25.5 %) were the two commonest reasons for ICU admission. Overall ICU mortality for obstetric patients was 54.3 % (n = 51) with average length of stay of 6.6 ± 7.525 days. MEOWS score was an independent predictor of mortality (adjusted (a)OR 1.25; 95 % CI 1.07–1.46) and so was qSOFA score (aOR 2.81; 95 % CI 1.25–6.30) with an adjusted AUROC of 0.773 (95 % CI 0.67–0.88) and 0.764 (95 % CI 0.65–0.87), indicating fair accuracy for ICU mortality prediction in these settings of both MEOWS and qSOFA scores. Conclusions Sepsis and obstetric haemorrhage were the commonest reasons for obstetric admissions to ICU in Rwanda. MEOWS and qSOFA scores could accurately predict ICU mortality of obstetric patients in resource-limited settings, but larger studies are needed before a recommendation for their use in routine practice in similar settings.


2020 ◽  
Author(s):  
Alcade Rudakemwa ◽  
Amy Lucille Cassidy ◽  
Theogene Twagirumugabe

Abstract Background Reasons for admission at the intensive care units (ICU) for obstetric patients vary from a setting to another. Outcomes from ICU and its prediction models are not well explored in Rwanda because of lack of appropriate scores. This study intended to assess profile and accuracy of predictive models for obstetric patients admitted in ICU in the two public tertiary hospitals in Rwanda.Methods We prospectively collected data from all obstetric patients admitted in the ICU of public referral hospitals in Rwanda from March 2017 to February 2018 to identify reasons for admissions and factors for prognosis. We analysed the accuracy of mortality prediction models including the quick Sequential Organ Failure Assessment (qSOFA) and Modified Early Obstetric Warning Score (MEOWS) by using the Logistic Regression and adjusted Receiver Operating characteristic (ROC) curves. Results Obstetric patients represented 12.8% of all ICU admissions and 1.8% of all deliveries. Sepsis (31.9%) and haemorrhage (25.5%) were the two commonest reasons for ICU admission in our study participants. The overall ICU mortality for our obstetric patients was 54.3% while the average length of stay was 6.6 days. MEOWS score was an independent predictor to mortality (adjusted OR=1.25[1.07-1.46]; p=0.005) and so was the qSOFA score (adjusted OR=2.81[1.25-6.30]; p=0.012). The adjusted Area Under the ROC (AUROC) for MEOWS was 0.773[0.666-0.880] and that of the qSOFA was 0.764[0.654-0.873] signing fair accuracies for ICU mortality prediction in these settings for both models.Conclusion Sepsis is the commonest reason for admissions to ICU for obstetric patients in Rwanda. Simple models comprising MEOWS and qSOFA could accurately predict the mortality for those patients but further larger studies are needed before generalization.


2021 ◽  
Vol 10 (11) ◽  
pp. 2490
Author(s):  
Giulio Francesco Romiti ◽  
Bernadette Corica ◽  
Gregory Y. H. Lip ◽  
Marco Proietti

Background: In patients with COVID-19, cardiovascular complications are common and associated with poor prognosis. Among these, an association between atrial fibrillation (AF) and COVID-19 has been described; however, the extent of this relationship is unclear. The aim of this study is to investigate the epidemiology of AF in COVID-19 patients and its impact on all-cause mortality. Methods: A systematic review and meta-analysis were performed and reported according to PRISMA guidelines, and a protocol for this study was registered on PROSPERO (CRD42021227950). PubMed and EMBASE were systematically searched for relevant studies. A random-effects model was used to estimate pooled odds ratios (OR) and 95% confidence intervals (CI). Results: Overall, 31 studies were included in the analysis, with a total number of 187,716 COVID-19 patients. The prevalence of AF was found to be as high as 8% of patients with COVID-19 (95% CI: 6.3–10.2%, 95% prediction intervals (PI): 2.0–27.1%), with a high degree of heterogeneity between studies; a multiple meta-regression model including geographical location, age, hypertension, and diabetes showed that these factors accounted for more than a third of the heterogeneity. AF COVID-19 patients were less likely to be female but more likely older, hypertensive, and with a critical status than those without AF. Patients with AF showed a significant increase in the risk of all-cause mortality (OR: 3.97, 95% CI: 2.76–5.71), with a high degree of heterogeneity. A sensitivity analysis focusing on new-onset AF showed the consistency of these results. Conclusions: Among COVID-19 patients, AF is found in 8% of patients. AF COVID-19 patients are older, more hypertensive, and more likely to have a critical status. In COVID-19 patients, AF is associated with a 4-fold higher risk of death. Further studies are needed to define the best treatment strategies to improve the prognosis of AF COVID-19 patients.


Author(s):  
Deepshikha Charan Ashana ◽  
George L Anesi ◽  
Vincent X Liu ◽  
Gabriel J Escobar ◽  
Christopher Chesley ◽  
...  

2020 ◽  
Vol 71 (16) ◽  
pp. 2079-2088 ◽  
Author(s):  
Kun Wang ◽  
Peiyuan Zuo ◽  
Yuwei Liu ◽  
Meng Zhang ◽  
Xiaofang Zhao ◽  
...  

Abstract Background This study aimed to develop mortality-prediction models for patients with coronavirus disease-2019 (COVID-19). Methods The training cohort included consecutive COVID-19 patients at the First People’s Hospital of Jiangxia District in Wuhan, China, from 7 January 2020 to 11 February 2020. We selected baseline data through the stepwise Akaike information criterion and ensemble XGBoost (extreme gradient boosting) model to build mortality-prediction models. We then validated these models by randomly collected COVID-19 patients in Union Hospital, Wuhan, from 1 January 2020 to 20 February 2020. Results A total of 296 COVID-19 patients were enrolled in the training cohort; 19 died during hospitalization and 277 discharged from the hospital. The clinical model developed using age, history of hypertension, and coronary heart disease showed area under the curve (AUC), 0.88 (95% confidence interval [CI], .80–.95); threshold, −2.6551; sensitivity, 92.31%; specificity, 77.44%; and negative predictive value (NPV), 99.34%. The laboratory model developed using age, high-sensitivity C-reactive protein, peripheral capillary oxygen saturation, neutrophil and lymphocyte count, d-dimer, aspartate aminotransferase, and glomerular filtration rate had a significantly stronger discriminatory power than the clinical model (P = .0157), with AUC, 0.98 (95% CI, .92–.99); threshold, −2.998; sensitivity, 100.00%; specificity, 92.82%; and NPV, 100.00%. In the subsequent validation cohort (N = 44), the AUC (95% CI) was 0.83 (.68–.93) and 0.88 (.75–.96) for the clinical model and laboratory model, respectively. Conclusions We developed 2 predictive models for the in-hospital mortality of patients with COVID-19 in Wuhan that were validated in patients from another center.


Sign in / Sign up

Export Citation Format

Share Document